A detailed history of Paradigm Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Paradigm Capital Management, LLC holds 3,345 shares of NVS stock, worth $358,182. This represents 0.44% of its overall portfolio holdings.

Number of Shares
3,345
Previous 3,445 2.9%
Holding current value
$358,182
Previous $262,000 15.65%
% of portfolio
0.44%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $7,555 - $9,252
-100 Reduced 2.9%
3,345 $303,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $13,056 - $15,270
-175 Reduced 4.83%
3,445 $262,000
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $40,260 - $46,875
-500 Reduced 12.14%
3,620 $306,000
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $18,024 - $20,389
-225 Reduced 5.18%
4,120 $362,000
Q4 2021

Feb 10, 2022

BUY
$79.7 - $88.13 $346,296 - $382,924
4,345 New
4,345 $380,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Paradigm Capital Management, LLC Portfolio

Follow Paradigm Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management, LLC with notifications on news.